Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial

被引：0
|
作者：
Aixin Shi
Panpan Xie
Lasse Lykke Nielsen
Trine Vang Skjøth
Xuemei He
Sine Pfeiffer Haugaard
机构：
[1] Chinese Academy of Medical Sciences,Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine
[2] Novo Nordisk A/S,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Diabetes; Glucagon-like peptide-1 receptor agonist; Pharmacokinetics; Randomised controlled trial; Semaglutide; Steady state exposure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：550 / 561
页数：11
相关论文
共 50 条
  • [41] Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability-Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study
    Markova, S.
    Baladi, M.
    Lee, M.
    Chen, C.
    MOVEMENT DISORDERS, 2024, 39 : S290 - S291
  • [42] Tolerability, safety, and pharmacokinetics of GR1603 injection in healthy subjects: a randomized, double-blind, placebo-controlled single-dose escalation clinical trial
    Huang, Xin
    Hong, Xiang
    Yang, Shuang
    Ye, Ling
    Yang, Xiaoyan
    Cui, Chang
    Wu, Qian
    Wang, Wei
    Huang, Jie
    Yang, Guoping
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2025, 34 (1-2) : 89 - 95
  • [43] A Phase I, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects
    Liu, Chao
    Lu, Hong
    Yuan, Fei
    Chen, Wei-Li
    Xu, Hong-Rong
    Li, Hui
    Hsu, Cheng-Pang
    Egbuna, Ogo
    Wu, Jihua
    Dias, Clapton
    Abosaleem, Bassam
    Rana, Jitesh
    Monsalvo, Maria Laura
    Li, Xue-Ning
    Yu, Zhigang
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2019, 11 : 145 - 153
  • [44] Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study
    Ratner, R.
    Nauck, M.
    Kapitza, C.
    Asnaghi, V.
    Boldrin, M.
    Balena, R.
    DIABETIC MEDICINE, 2010, 27 (05) : 556 - 562
  • [45] Pharmacokinetics and Safety of Golimumab in Healthy Chinese Subjects Following a Single Subcutaneous Administration in a Randomized Phase I Trial
    Zhuang, Yanli
    Lyn, Sally
    Lv, Yuan
    Xu, Zhenhua
    Bouman-Thio, Esther
    Masterson, Tara
    Ford, Joyce A.
    Keen, Monica
    Petty, Kevin J.
    Davis, Hugh M.
    Zhou, Honghui
    CLINICAL DRUG INVESTIGATION, 2013, 33 (11) : 795 - 800
  • [46] Pharmacokinetics and Safety of Golimumab in Healthy Chinese Subjects Following a Single Subcutaneous Administration in a Randomized Phase I Trial
    Yanli Zhuang
    Sally Lyn
    Yuan Lv
    Zhenhua Xu
    Esther Bouman-Thio
    Tara Masterson
    Joyce A. Ford
    Monica Keen
    Kevin J. Petty
    Hugh M. Davis
    Honghui Zhou
    Clinical Drug Investigation, 2013, 33 : 795 - 800
  • [47] A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous Garadacimab (CSL312) in Healthy Subjects
    McKenzie, Andrew
    Roberts, Anthony
    Malandkar, Sourabh
    Feuersenger, Henrike
    Panousis, Con
    Pawaskar, Dipti
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB137 - AB137
  • [48] A Randomized Clinical Trial of Safety, Pharmacokinetics, and Pharmacodynamics of Weekly Dosing Supagutide in Healthy Chinese Subjects
    Ma, Anran
    Zhou, Yue
    Lou, Yan-Ru
    Liao, Yijing
    Shao, Anna
    Wang, Zhihong
    Jiang, Yaojing
    Cui, Qiaoli
    Zhao, Ying
    Li, Jia
    PruD'Homme, Gerald J.
    Zhu, Dalong
    Wang, Qinghua
    DIABETES, 2022, 71
  • [49] The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial
    Zhang, Sheng-ting
    Tan, Hong-yi
    Yang, Shuang
    Yang, Xiao-yan
    Cui, Chang
    Huang, Jie
    Yang, Guo-ping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
  • [50] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Taylor, Lesley
    Gidal, Barry
    Blakey, Graham
    Tayo, Bola
    Morrison, Gilmour
    CNS DRUGS, 2018, 32 (11) : 1053 - 1067
12345